Work

Fragile sites are preferential targets for integrations of MLV vectors in gene therapy

Year: 2006

Type: article

Source: Gene Therapy

DOI: 10.1038/sj.gt.3302752

Authors: A C Bester, M Schwartz, M Schmidt, A Garrigue, S Hacein-Bey-Abina, M Cavazzana-Calvo, N Ben-Porat, C Von Kalle, A Fischer, B Kerem

Institutions: Hebrew University of Jerusalem, University of Freiburg, Inserm, Assistance Publique – Hôpitaux de Paris, Cincinnati Children's Hospital Medical Center, Hôpital Necker-Enfants Malades

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2056339293

FWCI: 3.888

Cites: 12

Cited by: 52

Related to: 10